Analgesic Efficacy of Intravenous Ibuprofen in Biliary Colic
Primary Purpose
Biliary Colic
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
IV Ibuprofen
Saline
Sponsored by
About this trial
This is an interventional treatment trial for Biliary Colic focused on measuring Biliary Colic, Abdominal pain, Intravenous Ibuprofen
Eligibility Criteria
Inclusion Criteria:
- Patients ages 18-55
- Present to ED with right upper quadrant (RUQ) abdominal pain
- Suspected diagnosis of biliary colic
- Negative pregnancy test for women of childbearing potential (complete POC testing form)
- No history of cholecystectomy
Exclusion Criteria:
- Patient age < 18 or > 55
- Incarcerated
- Hemodynamic instability
- Inability to reliably self-report or communicate pain intensity and pain relief
- Taking Warfarin
- Cannot consent of are not competent to consent
- Hepatic, renal, cardiac failure
- NSAID or morphine allergy
- History congenital bleeding diathesis or platelet dysfunction
- Peptic ulcer diseases
- Are otherwise unsuitable for the study in the opinion of the investigator/sub-investigators
Sites / Locations
- Maricopa Integrated Health System
Arms of the Study
Arm 1
Arm 2
Arm Type
Placebo Comparator
Active Comparator
Arm Label
Control Group: Adults age 18-55 years
IV Ibuprofen: Adults age 18-55 years
Arm Description
Saline-only control group
Patients receiving intravenous ibuprofen therapy
Outcomes
Primary Outcome Measures
Pain Score 120 Minutes After Study Medication Administration
Pain is measured on a visual analog scale 0=no pain and 10=worst pain imaginable.
Secondary Outcome Measures
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT02268955
Brief Title
Analgesic Efficacy of Intravenous Ibuprofen in Biliary Colic
Official Title
Assessment of the Analgesic Efficacy of Intravenous Ibuprofen in Biliary Colic
Study Type
Interventional
2. Study Status
Record Verification Date
March 2019
Overall Recruitment Status
Completed
Study Start Date
September 9, 2014 (Actual)
Primary Completion Date
June 21, 2017 (Actual)
Study Completion Date
June 28, 2017 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Valleywise Health
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
The aim of this study is to assess the analgesic efficacy of intravenous ibuprofen given in the Emergency Department for the treatment of biliary colic. We hypothesize that intravenous ibuprofen will provide a clinically significant drop in self-reported patient pain level as measured by the visual analog scale.
Detailed Description
It is estimated over 20 million people aged 20-74 have gallbladder disease, with biliary colic being a common and painful symptom in these patients. Likely due to the relatively recent approval of intravenous ibuprofen use for fever and pain in adults, no assessment of its analgesic efficacy for biliary colic currently exists in the literature.
Utilizing a visual analog scale (VAS) for patient self-assessment of pain, this study will address this lack of evidence and identify intravenous ibuprofen's value as a novel analgesic in the treatment of biliary colic. Patients will be given a VAS at the time of study therapy administration, at 15-minute intervals during the first hour post-administration, and 30-minute intervals in the second hour. Though NSAID's have been extensively studied in the management of this phenomenon, this study aims to help optimize pain treatment of patients presenting to the Emergency Department with biliary colic, and potentially pave the way for future analgesic treatment comparison studies.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Biliary Colic
Keywords
Biliary Colic, Abdominal pain, Intravenous Ibuprofen
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigator
Allocation
Randomized
Enrollment
22 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Control Group: Adults age 18-55 years
Arm Type
Placebo Comparator
Arm Description
Saline-only control group
Arm Title
IV Ibuprofen: Adults age 18-55 years
Arm Type
Active Comparator
Arm Description
Patients receiving intravenous ibuprofen therapy
Intervention Type
Drug
Intervention Name(s)
IV Ibuprofen
Other Intervention Name(s)
Caldolor, NeoProfen
Intervention Description
Intravenous ibuprofen will be administered for treatment of pain in adults presenting to the ED with biliary colic
Intervention Type
Drug
Intervention Name(s)
Saline
Intervention Description
Saline will be administered to the placebo group
Primary Outcome Measure Information:
Title
Pain Score 120 Minutes After Study Medication Administration
Description
Pain is measured on a visual analog scale 0=no pain and 10=worst pain imaginable.
Time Frame
120 minutes post medication administration
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
55 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Patients ages 18-55
Present to ED with right upper quadrant (RUQ) abdominal pain
Suspected diagnosis of biliary colic
Negative pregnancy test for women of childbearing potential (complete POC testing form)
No history of cholecystectomy
Exclusion Criteria:
Patient age < 18 or > 55
Incarcerated
Hemodynamic instability
Inability to reliably self-report or communicate pain intensity and pain relief
Taking Warfarin
Cannot consent of are not competent to consent
Hepatic, renal, cardiac failure
NSAID or morphine allergy
History congenital bleeding diathesis or platelet dysfunction
Peptic ulcer diseases
Are otherwise unsuitable for the study in the opinion of the investigator/sub-investigators
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Dan Quan, DO
Organizational Affiliation
Valleywise Health
Official's Role
Principal Investigator
Facility Information:
Facility Name
Maricopa Integrated Health System
City
Phoenix
State/Province
Arizona
ZIP/Postal Code
85008
Country
United States
12. IPD Sharing Statement
Citations:
PubMed Identifier
21127424
Citation
Promes JT, Safcsak K, Pavliv L, Voss B, Rock A. A prospective, multicenter, randomized, double-blind trial of IV ibuprofen for treatment of fever and pain in burn patients. J Burn Care Res. 2011 Jan-Feb;32(1):79-90. doi: 10.1097/BCR.0b013e3182037300.
Results Reference
background
PubMed Identifier
14622683
Citation
Jensen MP, Chen C, Brugger AM. Interpretation of visual analog scale ratings and change scores: a reanalysis of two clinical trials of postoperative pain. J Pain. 2003 Sep;4(7):407-14. doi: 10.1016/s1526-5900(03)00716-8.
Results Reference
background
PubMed Identifier
20595477
Citation
Krudsood S, Tangpukdee N, Wilairatana P, Pothipak N, Duangdee C, Warrell DA, Looareesuwan S. Intravenous ibuprofen (IV-ibuprofen) controls fever effectively in adults with acute uncomplicated Plasmodium falciparum malaria but prolongs parasitemia. Am J Trop Med Hyg. 2010 Jul;83(1):51-5. doi: 10.4269/ajtmh.2010.09-0621.
Results Reference
background
PubMed Identifier
20591173
Citation
Morris PE, Promes JT, Guntupalli KK, Wright PE, Arons MM. A multi-center, randomized, double-blind, parallel, placebo-controlled trial to evaluate the efficacy, safety, and pharmacokinetics of intravenous ibuprofen for the treatment of fever in critically ill and non-critically ill adults. Crit Care. 2010;14(3):R125. doi: 10.1186/cc9089. Epub 2010 Jun 30.
Results Reference
background
PubMed Identifier
20609131
Citation
Singla N, Rock A, Pavliv L. A multi-center, randomized, double-blind placebo-controlled trial of intravenous-ibuprofen (IV-ibuprofen) for treatment of pain in post-operative orthopedic adult patients. Pain Med. 2010 Aug;11(8):1284-93. doi: 10.1111/j.1526-4637.2010.00896.x. Epub 2010 Jun 30.
Results Reference
background
PubMed Identifier
20642488
Citation
Kroll PB, Meadows L, Rock A, Pavliv L. A multicenter, randomized, double-blind, placebo-controlled trial of intravenous ibuprofen (i.v.-ibuprofen) in the management of postoperative pain following abdominal hysterectomy. Pain Pract. 2011 Jan-Feb;11(1):23-32. doi: 10.1111/j.1533-2500.2010.00402.x.
Results Reference
background
PubMed Identifier
19843482
Citation
Southworth S, Peters J, Rock A, Pavliv L. A multicenter, randomized, double-blind, placebo-controlled trial of intravenous ibuprofen 400 and 800 mg every 6 hours in the management of postoperative pain. Clin Ther. 2009 Sep;31(9):1922-35. doi: 10.1016/j.clinthera.2009.08.026.
Results Reference
background
PubMed Identifier
22316349
Citation
Smith HS, Voss B. Pharmacokinetics of intravenous ibuprofen: implications of time of infusion in the treatment of pain and fever. Drugs. 2012 Feb 12;72(3):327-37. doi: 10.2165/11599230-000000000-00000.
Results Reference
background
PubMed Identifier
22540869
Citation
Colli A, Conte D, Valle SD, Sciola V, Fraquelli M. Meta-analysis: nonsteroidal anti-inflammatory drugs in biliary colic. Aliment Pharmacol Ther. 2012 Jun;35(12):1370-8. doi: 10.1111/j.1365-2036.2012.05115.x. Epub 2012 Apr 29.
Results Reference
background
PubMed Identifier
12426013
Citation
Henderson SO, Swadron S, Newton E. Comparison of intravenous ketorolac and meperidine in the treatment of biliary colic. J Emerg Med. 2002 Oct;23(3):237-41. doi: 10.1016/s0736-4679(02)00524-3.
Results Reference
background
PubMed Identifier
18637080
Citation
Olsen JC, McGrath NA, Schwarz DG, Cutcliffe BJ, Stern JL. A double-blind randomized clinical trial evaluating the analgesic efficacy of ketorolac versus butorphanol for patients with suspected biliary colic in the emergency department. Acad Emerg Med. 2008 Aug;15(8):718-22. doi: 10.1111/j.1553-2712.2008.00178.x. Epub 2008 Jul 11.
Results Reference
background
Learn more about this trial
Analgesic Efficacy of Intravenous Ibuprofen in Biliary Colic
We'll reach out to this number within 24 hrs